leisure time -WSS

leisure time

author：Wikipedia 2025-10-06 19:10:07 - browse：6424

Adobe

The medical device industry is split on whether a proposed new Medicare reimbursement pathway will do anything to soothe their insurance coverage woes.

Device makers have long complained that the unclear, rocky road to payment kills innovative companies. So they were thrilled when the Trump administration proposed a rule that would have guaranteed four years of Medicare coverage of approved devices deemed “breakthroughs” by the Food and Drug Administration. They hoped private payers would follow suit. But in 2021, under a new administration and a push for more device scrutiny, the Centers for Medicare and Medicaid pulled back on the idea, promising a replacement that would streamline coverage for innovative devices while ensuring safe, high-quality care.

The pathway put forth last week, called Transitional Coverage for Emerging Technologies (TCET), is only a notice, not yet a rule that would grant CMS new powers. The program applies solely to devices that have earned a place in the FDA’s breakthrough device program, which was established to identify devices that the agency believed could provide “more effective” treatment or diagnosis of serious conditions than the current standard of care. But because those devices can be brought to market with less certainty in their benefits and risks than other products, experts said, the idea of automatic reimbursement was dicey.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Community addresses injustice for Long Island mothers

hotspot

WSS

Why is France rioting? What to know about the fatal police shooting of Nahel M

Newly revealed memo details efforts to keep Trump in power following election loss

Some of the ways extreme heat will change life as we know it

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

Connecting traumatic brain injury and domestic violence

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

knowledge

leisure time

focus

Drug repurposing or repositioning? The language matters

Listen: Your guide to Wegovy's blockbuster heart study

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Connecting traumatic brain injury and domestic violence

Bright Health sells Medicare Advantage business to Molina

When is a doctor not a doctor? Try when patients address women doctors

Cancer drug shortages should be causing more outrage

New case study details death in closely watched Alzhiemer's trial

BioMarin wins approval for gene therapy to treat hemophilia A

PhRMA sues HHS over Medicare drug price negotiation

Wikipedia

PhRMA sues HHS over Medicare drug price negotiation

Inside the fall of star MIT scientist David Sabatini

The history of OxyContin, told through Purdue Pharma documents

CDC overhauls leadership of center that led response to Covid

Why is France rioting? What to know about the fatal police shooting of Nahel M

Maui funeral service workers on devastation of fires: 'I'm in shock'

hotspot

focus

Wikipedia

leisure time